These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36706644)

  • 1. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J
    Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of COVID-19 pandemic on molar pregnancy and postmolar gestational trophoblastic neoplasia: An observational study.
    Campos V; Paiva G; Padron L; Freitas F; Pedrotti LG; Sun SY; Viggiano M; Oliveira L; Rohr L; Madi JM; Arrym TP; Oliveira P; Dos Santos Esteves APV; Junior JA; Filho JR; Elias KM; Horowitz NS; Braga A; Berkowitz RS
    BJOG; 2023 Feb; 130(3):292-302. PubMed ID: 36209485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for gestational trophoblastic neoplasia development of singleton normal fetus with partial hydatidiform mole pregnancy: A retrospective cohort and literature review.
    Zhong L; Song L; Yin R; Li Q; Wang D
    J Obstet Gynaecol Res; 2023 Feb; 49(2):479-486. PubMed ID: 36328803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil/lymphocyte ratio and other blood cell component counts are not associated with the development of postmolar gestational trophoblastic neoplasia.
    Braga A; Canelas AC; Torres B; Maesta I; Giongo Pedrotti L; Bessel M; Vieira Dos Santos Esteves AP; Amim Junior J; Rezende Filho J; Elias KM; Horowitz NS; Berkowitz RS
    PLoS One; 2022; 17(12):e0277892. PubMed ID: 36454778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.